Rapid, proteomic urine assay for monitoring progressive organ disease in Fabry disease.

Ivan D DoykovWendy E HeywoodValeria NikolaenkoJustyna ŚpiewakJenny HällqvistPeter Theodore ClaytonPhilippa MillsDavid G WarnockAlbina Nowak Kevin A Mills

Published in: Journal of medical genetics (2019)

This work indicates that protein biomarkers could be helpful and used in conjunction with plasma lyso-Gb3 for monitoring of therapy or disease progression in patients with Fabry disease.

Keyphrases

stem cells
heart failure
high throughput
mesenchymal stem cells
binding protein
single cell
cell therapy
quantum dots
sensitive detection
label free